Cannabis & Psychiatry

Medicinal cannabis has entered increased exploration attention over recent times due to loosening global nonsupervisory changes. The present substantiation in the arising field of cannabinoid rectifiers in psychiatry is incipient, and thereby it's presently unseasonable to recommend cannabinoid- grounded interventions. insulated positive studies have, still, revealed conditional support for cannabinoids for reducing social anxiety. While there's adding psychiatric interest regarding the implicit internal health operations, literal substantiation for the use of cannabis in internal health conditions is remarkably ancient.

    Related Conference of Cannabis & Psychiatry

    July 20-21, 2026

    37th World Congress on Neurology and Neuroscience

    Amsterdam, Netherlands
    July 23-24, 2026

    14th International Conference on Cannabis & Medicinal Research

    Amsterdam, Netherlands
    September 18-19, 2026

    21st Annual Congress on Neuroscience

    Dubai, UAE
    November 16-17, 2026

    8th World Brain Congress

    Tokyo, Japan
    November 23-24, 2026

    16th Global Alzheimers Summit

    Paris, France
    November 24-25, 2026

    38th World Conference on Neurology

    Rome, Italy
    December 16-17, 2026

    12th International Conference on Brain Injury & Neuro Surgeons

    Amsterdam, Netherlands
    December 21-22, 2026

    6th International Conference on Child Neurology

    Paris, France
    December 28-29, 2026

    39th European Neurology Congress

    Amsterdam, Netherlands
    December 28-29, 2026

    18th Global Neurologists Meeting on Neurology and Neurosurgery

    Amsterdam, Netherlands
    March 22-23, 2027

    8th International Conference on Neurologists

    Singapore City, Singapore
    March 24-25, 2027

    38th Conference on Clinical Neuroscience and Neurogenetics

    Geneva, Switzerland

    Cannabis & Psychiatry Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in